BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28229162)

  • 1. Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction.
    Hayakawa M; Kushimoto S; Watanabe E; Goto K; Suzuki Y; Kotani T; Kiguchi T; Yatabe T; Tagawa J; Komatsu F; Gando S
    Thromb Haemost; 2017 May; 117(5):851-859. PubMed ID: 28229162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic analysis of thrombomodulin alfa to support dosing rationale in patients with renal impairment.
    Mouksassi MS; Marier JF; Bax L; Osawa Y; Tsuruta K
    Clin Pharmacol Drug Dev; 2015; 4(3):210-7. PubMed ID: 27140801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of recombinant soluble thrombomodulin in disseminated intravascular coagulation patients with renal impairment.
    Hayakawa M; Yamamoto H; Honma T; Mukai N; Higashiyama A; Sugano M; Kubota N; Uegaki S; Sawamura A; Gando S
    Shock; 2012 Jun; 37(6):569-73. PubMed ID: 22552020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial.
    Saito H; Maruyama I; Shimazaki S; Yamamoto Y; Aikawa N; Ohno R; Hirayama A; Matsuda T; Asakura H; Nakashima M; Aoki N
    J Thromb Haemost; 2007 Jan; 5(1):31-41. PubMed ID: 17059423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based analysis of covariate effects on population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation and normal subjects.
    Tsuruta K; Yamada Y; Serada M; Tanigawara Y
    J Clin Pharmacol; 2011 Sep; 51(9):1276-85. PubMed ID: 21098690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.
    Yokoyama H; Takahashi N; Katsuoka Y; Inomata M; Ito T; Meguro K; Kameoka Y; Tsumanuma R; Murai K; Noji H; Ishizawa K; Ito S; Onishi Y; Harigae H;
    Int J Hematol; 2017 May; 105(5):606-613. PubMed ID: 28176226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin α) in Pediatric Patients With Disseminated Intravascular Coagulation.
    Shirahata A; Mimuro J; Takahashi H; Tsuji H; Kitajima I; Matsushita T; Eguchi Y; Kitamura N; Honda G; Sakata Y
    Clin Appl Thromb Hemost; 2014 Jul; 20(5):465-72. PubMed ID: 24563247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
    Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
    Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
    Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
    Vincent JL; Ramesh MK; Ernest D; LaRosa SP; Pachl J; Aikawa N; Hoste E; Levy H; Hirman J; Levi M; Daga M; Kutsogiannis DJ; Crowther M; Bernard GR; Devriendt J; Puigserver JV; Blanzaco DU; Esmon CT; Parrillo JE; Guzzi L; Henderson SJ; Pothirat C; Mehta P; Fareed J; Talwar D; Tsuruta K; Gorelick KJ; Osawa Y; Kaul I
    Crit Care Med; 2013 Sep; 41(9):2069-79. PubMed ID: 23979365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of a novel recombinant human soluble thrombomodulin, ART-123.
    Moll S; Lindley C; Pescatore S; Morrison D; Tsuruta K; Mohri M; Serada M; Sata M; Shimizu H; Yamada K; White GC
    J Thromb Haemost; 2004 Oct; 2(10):1745-51. PubMed ID: 15456485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
    Yamakawa K; Aihara M; Ogura H; Yuhara H; Hamasaki T; Shimazu T
    J Thromb Haemost; 2015 Apr; 13(4):508-19. PubMed ID: 25581687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
    Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K
    Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.
    Tamura K; Saito H; Asakura H; Okamoto K; Tagawa J; Hayakawa T; Aoki N
    Int J Clin Oncol; 2015 Aug; 20(4):821-8. PubMed ID: 25385713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of thrombomodulin alfa in pediatric patients with hematological malignancy and disseminated intravascular coagulation.
    Takeuchi M; Tanoshima R; Miyagawa N; Sarashina T; Kato H; Kajiwara R; Ito S; Goto H
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27734584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
    Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
    J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation.
    Kobayashi T; Kajiki M; Nihashi K; Honda G
    Thromb Res; 2017 Nov; 159():109-115. PubMed ID: 29153952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.